Adaptive immunity in ankylosing spondylitis: Phenotype and functional alterations of T-cells before and during infliximab therapy

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Szalay, Balázs ^a   Mészáros, Gergo ^a   Cseh, Áron ^a   Ács, Lilla ^b   Deák, Magdolna ^b   Kovács, László ^b   Vásárhelyi, Barna ^a,c   Balog, Attila ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; INFLIXIMAB; NITRIC OXIDE; MONOCLONAL ANTIBODY;

ADAPTIVE IMMUNITY; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD; CALCIUM CELL LEVEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOREGULATION; INTRACELLULAR SIGNALING; MALE; MITOCHONDRION; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; TH2 CELL; TREATMENT RESPONSE; CLINICAL TRIAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; T LYMPHOCYTE; TREATMENT OUTCOME;

ADAPTIVE IMMUNITY; ADULT; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHENOTYPE; SPONDYLITIS, ANKYLOSING; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 81555227849     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/808724     Document Type: Article

References (37)

1. Braun J., Sieper J., Ankylosing spondylitis The Lancet 2007 369 9570 1379 1390 (Pubitemid 46590387)
2. Zhang X., Aubin J. E., Inman R. D., Molecular and cellular biology of new bone formation: insights into the ankylosis of ankylosing spondylitis Current Opinion in Rheumatology 2003 15 4 387 393 (Pubitemid 36774249)
3. Colbert R. A., Delay M. L., Klenk E. I., Layh-Schmitt G., From HLA-B27 to spondyloarthritis: a journey through the ER Immunological Reviews 2010 233 1 181 202
4. van der Horst-Bruinsma I. E., Lems W. F., Dijkmans B. A., A systematic comparison of rheumatoid arthritis and ankylosing spondylitis Clinical and Experimental Rheumatology 2009 27 4, supplement 55 S43 S49
5. Yang P. T., Kasai H., Zhao L. J., Xiao W. G., Tanabe F., Ito M., Increased CCR4 expression on circulating CD4+ T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus Clinical and Experimental Immunology 2004 138 2 342 347 (Pubitemid 39472454)
6. Jandus C., Bioley G., Rivals J. P., Dudler J., Speiser D., Romero P., Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides Arthritis and Rheumatism 2008 58 8 2307 2317
7. Wu Y., Ren M., Yang R., Liang X., Ma Y., Tang Y., Huang L., Ye J., Chen K., Wang P., Shen H., Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+Th/Treg cell subset imbalance in ankylosing spondylitis Arthritis Research and Therapy 2011 13 1, article R29
8. Nagy G., Clark J. M., Buzas E., Gorman C., Pasztoi M., Koncz A., Falus A., Cope A. P., Nitric oxide production of T lymphocytes is increased in rheumatoid arthritis Immunology Letters 2008 118 1 55 58
9. Sieper J., Braun J., Rudwaleit M., Boonen A., Zink A., Ankylosing spondylitis: an overview Annals of the Rheumatic Diseases 2002 61 3 iii8 iii18
10. Ferkolj I., Ihan A., Markovi S., Veeri Z., Pohar M., Infliximab reduces the number of activated mucosal lymphocytes in patients with Crohn's disease Journal of Gastrointestinal and Liver Diseases 2006 15 3 231 235 (Pubitemid 44483090)
11. Chen X., Oppenheim J. J., TNF- : an activator of CD4+FoxP3+TNFR2+ regulatory T cells Current Directions in Autoimmunity 2010 11 119 134
12. Aeberli D., Seitz M., Jni P., Villiger P. M., Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF- inhibitors Rheumatology 2005 44 2 172 175 (Pubitemid 40277397)
13. Van Der Linden S., Valkenburg H. A., Cats A., Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis and Rheumatism 1984 27 4 361 368 (Pubitemid 14134775)
14. Garrett S., Jenkinson T., Kennedy L. G., Whitelock H., Gaisford P., Calin A., A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index Journal of Rheumatology 1994 21 12 2286 2291
15. Mészros G., Szalay B., Toldi G., Kinetic measurements using flow cytometry: new methods for Monitoring intracellular processes. ASSAY and Drug Development Technologies. In press
16. Kaposi A. S., Veress G., Vsrhelyi B., Macardle P., Bailey S., Tulassay T., Treszl A., Cytometry-acquired calcium-flux data analysis in activated lymphocytes Cytometry Part A 2008 73 3 246 253 (Pubitemid 351324808)
17. Inman R. D., El-Gabalawy H. S., The immunology of ankylosing spondylitis and rheumatoid arthritis: a tale of similarities and dissimilarities Clinical and Experimental Rheumatology 2009 27 4 S26 S32
18. Duftner C., Goldberger C., Falkenbach A., Wrzner R., Falkensammer B., Pfeiffer K. P., Maerker-Hermann E., Schirmer M., Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis Arthritis Research amp; Therapy 2003 5 5 R292 R300
19. Schirmer M., Goldberger C., Wrzner R., Duftner C., Pfeiffer K. P., Clausen J., Neumayr G., Falkenbach A., Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis Arthritis Research 2002 4 1 71 76 (Pubitemid 34100492)
20. Rudwaleit M., Siegert S., Yin Z., Eick J., Thiel A., Radbruch A., Sieper J., Braun J., Low T cell production of TNF and IFN in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism Annals of the Rheumatic Diseases 2001 60 1 36 42 (Pubitemid 32038951)
21. Banica L., Besliu A., Pistol G., Stavaru C., Ionescu R., Forsea A. M., Tanaseanu C., Dumitrache S., Otelea D., Tamsulea I., Tanaseanu S., Chitonu C., Paraschiv S., Balteanu M., Stefanescu M., Matache C., Quantification and molecular characterization of regulatory T cells in connective tissue diseases Autoimmunity 2009 42 1 41 49
22. Langrish C. L., Chen Y., Blumenschein W. M., Mattson J., Basham B., Sedgwick J. D., McClanahan T., Kastelein R. A., Cua D. J., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation Journal of Experimental Medicine 2005 201 2 233 240 (Pubitemid 40189432)
23. Murphy C. A., Langrish C. L., Chen Y., Blumenschein W., McClanahan T., Kastelein R. A., Sedgwick J. D., Cua D. J., Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation Journal of Experimental Medicine 2003 198 12 1951 1957 (Pubitemid 38032126)
24. Liu W., Putnam A. L., Xu-yu Z., Szot G. L., Lee M. R., Zhu S., Gottlieb P. A., Kapranov P., Gingeras T. R., De S. G. B. F., Clayberger C., Soper D. M., Ziegler S. F., Bluestone J. A., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells Journal of Experimental Medicine 2006 203 7 1701 1711 (Pubitemid 44036276)
25. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., Solomon M., Selby W., Alexander S. I., Nanan R., Kelleher A., De S. G. B. F., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells Journal of Experimental Medicine 2006 203 7 1693 1700 (Pubitemid 44036275)
26. Klein S., Kretz C. C., Krammer P. H., Kuhn A., CD127 (low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood Journal of Investigative Dermatology 2010 130 2 492 499
27. Bossowski A., Urban M., Stasiak-Barmuta A., Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases Journal of Pediatric Endocrinology and Metabolism 2003 16 1 63 70 (Pubitemid 37259094)
28. Dejaco C., Duftner C., Klauser A., Schirmer M., Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica Rheumatology International 2010 30 3 297 303
29. Cauli A., Dessole G., Fiorillo M. T., Vacca A., Mameli A., Bitti P., Passiu G., Sorrentino R., Mathieu A., Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease Rheumatology 2002 41 12 1375 1379 (Pubitemid 36004313)
30. Gratacos J., Collado A., Filella X., Sanmarti R., Canete J., Llena J., Molina R., Ballesta A., Munoz-Gomez J., Serum cytokines (IL-6, TNF-, IL- and IFN- ) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity British Journal of Rheumatology 1994 33 10 927 931 (Pubitemid 24324807)
31. Sonel B., Tutkak H., Dzgn N., Serum levels of IL-1beta, TNF-alpha, IL-8, and acute phase proteins in seronegative spondyloarthropathies Joint Bone Spine 2002 69 5 463 467 (Pubitemid 35397723)
32. Aspalter R. M., Wolf H. M., Eibl M. M., Chronic TNF- exposure impairs TCR-signaling via TNF-RII but not TNF-RI Cellular Immunology 2005 237 1 55 67 (Pubitemid 41821082)
33. Church L. D., Goodall J. E., Rider D. A., Bacon P. A., Young S. P., Persistent TNF- exposure impairs store operated calcium influx in CD4+ T lymphocytes FEBS Letters 2005 579 6 1539 1544 (Pubitemid 40289209)
34. Lee H.-T., Chen W.-S., Chen M.-H., Tsai C.-Y., Chou C.-T., The expression of proinflammatory cytokines and intracellular minerals in patients with ankylosing spondylitis Formosan Journal of Rheumatology 2009 23 1 40 46
35. Nagy G., Koncz A., Perl A., T cell activation-induced mitochondrial hyperpolarization is mediated by Ca2+- and redox-dependent production of nitric oxide Journal of Immunology 2003 171 10 5188 5197 (Pubitemid 37432803)
36. Nagy G., Clark J. M., Buzs E. I., Gorman C. L., Cope A. P., Nitric oxide, chronic inflammation and autoimmunity Immunology Letters 2007 111 1 1 5 (Pubitemid 47017476)
37. Ferret-Bernard S., Sa P., Bach J. M., In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells Immunology Letters 2004 91 2-3 221 227 (Pubitemid 38296382)